Singapore markets open in 21 minutes

Axsome Therapeutics, Inc. (0HKF.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
73.39-2.17 (-2.87%)
At close: 06:43PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.12
52-week change 316.98%
S&P500 52-week change 326.27%
52-week high 398.17
52-week low 30.00
50-day moving average 385.35
200-day moving average 375.30

Share statistics

Avg vol (3-month) 3562
Avg vol (10-day) 3357
Shares outstanding 529.81M
Implied shares outstanding 6N/A
Float 835M
% held by insiders 117.04%
% held by institutions 184.50%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -118.07%
Operating margin (ttm)-91.58%

Management effectiveness

Return on assets (ttm)-32.76%
Return on equity (ttm)-231.68%

Income statement

Revenue (ttm)251.02M
Revenue per share (ttm)5.41
Quarterly revenue growth (yoy)-20.70%
Gross profit (ttm)N/A
EBITDA -244.54M
Net income avi to common (ttm)-296.38M
Diluted EPS (ttm)-3.72
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)331.44M
Total cash per share (mrq)6.98
Total debt (mrq)189.43M
Total debt/equity (mrq)131.52%
Current ratio (mrq)3.20
Book value per share (mrq)3.04

Cash flow statement

Operating cash flow (ttm)-192.73M
Levered free cash flow (ttm)-106.98M